Literature DB >> 21160622

Perspectives on the treatment of colorectal carcinoma.

Ren Zhao1, Jing Li.   

Abstract

Colorectal cancer includes cancerous growths in the colon, rectum and appendix. With 655000 deaths worldwide per year, it is the third most common form of cancer and the second leading cause of cancer-related death in the Western world. Advances in imaging, genetics, molecular diagnostics, surgical techniques and chemotherapy are now making significant gains in our ability to prevent, diagnose, and treat this serious disease. This article reviews some of these recent successes and shares a vision of future care based on current research.

Entities:  

Keywords:  Chemoprevention; Chemotherapy; Colorectal carcinoma; Endoscopic submucosal surgery; Resection margin; Screening technology; Treatment

Year:  2010        PMID: 21160622      PMCID: PMC2999184          DOI: 10.4251/wjgo.v2.i5.229

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  32 in total

1.  A smarter strategy? Reflections on fecal DNA screening for colorectal cancer.

Authors:  Steven H Woolf
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

2.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

3.  Endoscopic mucosal resection for treatment of early gastric cancer.

Authors:  H Ono; H Kondo; T Gotoda; K Shirao; H Yamaguchi; D Saito; K Hosokawa; T Shimoda; S Yoshida
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum.

Authors:  T Uraoka; Y Saito; T Matsuda; H Ikehara; T Gotoda; D Saito; T Fujii
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

Review 5.  Chemoprevention of colorectal neoplasia: advances and controversies (the COX-2 story).

Authors:  Robert S Bresalier
Journal:  Curr Opin Gastroenterol       Date:  2007-01       Impact factor: 3.287

6.  Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: what is now the appropriate distal resection margin?

Authors:  James J Mezhir; Kerrington D Smith; Alessandro Fichera; John Hart; Mitchell C Posner; Roger D Hurst
Journal:  Surgery       Date:  2005-10       Impact factor: 3.982

Review 7.  Colorectal carcinoma: Importance of colonic environment for anti-cancer response and systemic immunity.

Authors:  Luca Vannucci; Renata Stepankova; Valeria Grobarova; Hana Kozakova; Pavel Rossmann; Klara Klimesova; Veronika Benson; Petr Sima; Anna Fiserova; Helena Tlaskalova-Hogenova
Journal:  J Immunotoxicol       Date:  2009-12       Impact factor: 3.000

8.  Endoscopic submucosal dissection (ESD) for colorectal tumors.

Authors:  Yutaka Saito; Taku Sakamoto; Shusei Fukunaga; Takeshi Nakajima; Shinsuke Kiriyama; Shinsuke Kuriyama; Takahisa Matsuda
Journal:  Dig Endosc       Date:  2009-07       Impact factor: 7.559

9.  Thin endoscope-assisted endoscopic submucosal dissection for large colorectal tumors (with videos).

Authors:  Toshio Uraoka; Jun Kato; Shin Ishikawa; Keita Harada; Motoaki Kuriyama; Koji Takemoto; Yoshiro Kawahara; Yutaka Saito; Hiroyuki Okada
Journal:  Gastrointest Endosc       Date:  2007-10       Impact factor: 9.427

10.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

View more
  2 in total

1.  Identification of differential gene expressions in colorectal cancer and polyp by cDNA microarray.

Authors:  Yi-Chen Dai; Xiao-San Zhu; Qing-Zhen Nan; Zhang-Xin Chen; Jun-Pei Xie; Yu-Ka Fu; Yuan-Yuan Lin; Qing-Na Lian; Qiao-Fang Sang; Xiao-Juan Zhan
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

2.  Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer.

Authors:  Ki Young Choi; Eun Jung Jeon; Hong Yeol Yoon; Beom Suk Lee; Jin Hee Na; Kyung Hyun Min; Sang Yoon Kim; Seung-Jae Myung; Seulki Lee; Xiaoyuan Chen; Ick Chan Kwon; Kuiwon Choi; Seo Young Jeong; Kwangmeyung Kim; Jae Hyung Park
Journal:  Biomaterials       Date:  2012-06-09       Impact factor: 12.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.